Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 4, 2005, Pages 846-852

  Chaiworaporn, Ruangyuth ^a   Maneerat, Yaowapa ^a   Rojekittikhun, Wichit ^a   Ramasoota, Pongrama ^a   Janecharut, Tuenta ^b   Matsuda, Hajime ^c   Kitikoon, Viroj ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SILPAKORN UNIVERSITY   (Thailand)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27744590881     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Botros S, Soliman A, El-Gawhary N, Selim M, Guirguis N. Effect of combined low dose praziquantel and oxamniquine on different stages of schistsosome maturity. Trans R Soc Trop Med Hyg 1989; 83: 86-9.
2. Cioli D. Chemotherapy of schistosomiasis: an update. Parasitol Today 1998; 14: 418-22.
3. Fallon PG, Doenhoeff MJ. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 1994; 51: 83-8.
4. Fallon PG, Fookes RE, Wharton GA. Temporal difference in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications of drug-antibody synergy. Parasitol 1996; 112: 47-58.
5. Fallon PG, Hamilton JV, Doenhoeff MJ. Efficacy of treatment murine Schistosoma mansoni infection with praziquantel and oxamniquine correlates with infection intensity: role of host antibody. Parasitology 1995; 111: 59-66.
6. Giboda M, Smith JM. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice. J Trop Med Hyg 1994; 97: 98-102.
7. Giboda M, Smith JM, Prichard RK. Reduction in tissue egg load and maintenance of resistance to challenge in mice infected with Schistosoma mansoni, following combined treatment with praziquantel and an antifibrotic agent. Ann Trop Med Parasitol 1994; 88: 385-95.
8. Matsuda H, Tanaka H, Nogami S, Muto M. Mechanism of action of praziquantel on the eggs of Schistosoma japonicum. Jpn J Exp Med 1983; 53: 271-4.
9. Moloney NA, Hinchcliffe P, Webbe G. Loss of resistance to reinfection with Schistosoma japonicum in mice after treatment with praziquantel. Trans R Soc Trop Med Hyg 1987; 81: 247-54.
10. Ridi RE, Mahrous A, Afifi A, Montash M, Velek J, Jezek J. Human and murine humeral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to schistosomiasis. Scand J Immunol 2001; 54: 477-85.
11. Shaw MK. Schistosoma mansoni: stage dependent damage after in vivo treatment with praziquantel. Parasitology 1990; 100: 65-72.
12. Shaw MK, Erasmus A. Schistosoma mansoni: praziquantel-induced changes to the female reproductive system. Exp Parasitol 1988; 65: 31-42.
13. Stanley Jr SL. Antiparasitic agents. In: Cohen J, Powderly WG. eds. Infectious diseases. Vol 2. 2nd ed. Edinburgh: Mosby, 2004: 1941-60.
14. Terry RJ. Human immunity to schistosomes: concomitant immunity? Parasitol Today 1994; 10:377-8.
15. Wilkins HA. Reinfection after treatment of schistosome infections. Parasitol Today 1989; 5: 83-8.
16. nd ed. Geneva: World Health Organization, 1995.